My Abstract Submissions

My Author Disclosure Submissions

TITLE OF ABSTRACT:Combination of Autologous and Allogeneic AML-DCs is a Potent CTL Inducer: Prospective Use in AML Immunotherapy

AUTHOR NAME:

Seyed Saide Moazzeni

AUTHOR NAME:

Seyed Saide Moazzeni

TITLE OF ABSTRACT:

Combination of Autologous and Allogeneic AML-DCs is a Potent CTL Inducer: Prospective Use in AML Immunotherapy

Please complete

PLEASE COMPLETE ALL SECTIONS AND SIGN BELOW

Affiliations, if any:

I DO NOT have an affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

I have/had an affiliation

Complete the section below as it applies to you during the past two calendar years. Please indicate the commercial organization(s) with which you have/had affiliations, and briefly explain what connection you have/had with the organization. You must disclose this information to your audience

I DO NOT have an affiliation

Speakers who have no involvement with industry should inform the audience that they cannot identify any conflict of interest.

Affliation(s)

DISCLOSURE/CONFLICT OF INTEREST DECLARATION

Acknowledgment:

I acknowledge that the above information is accurate and I understand that this information will be publicly available.

Name

Seyed Saide Moazzeni

Signature

Entry Date

June 4, 2018